“Obesity is the number-one health problem in the United States because it negatively affects our population’s health more than any other condition,” said Kaiser Permanente Washington Health Research Institute senior investigator David Arterburn, MD, MPH. Kaiser Permanente Washington researchers are doing practical research to learn how doctors, patients, families, employers, and policymakers can best work together to prevent and treat obesity.
“We’re focusing on three ways to halt the obesity epidemic,” said associate investigator Dori Rosenberg, PhD, MPH. “We’re helping to change obesity-promoting environments, bringing evidence-based prevention and treatment programs into health care systems, and helping people develop lifelong healthy diet and activity habits.”
Kaiser Permanente Washington obesity research areas include:
“Obesity is caused by many factors, so at Kaiser Permanente Washington, we’re working on many levels,” said Paula Lozano, MD, MPH, a senior investigator and Kaiser Permanente Washington’s assistant medical director for preventive care. “We’re improving health care to help people who are obese now. But since obesity is a societal problem, we’re also studying how to change our homes and workplaces and neighborhoods to create more healthy environments.”
Arterburn D, Lewis KH. Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass. JAMA Netw Open. 2021;4(9):e2122541. doi: 10.1001/jamanetworkopen.2021.22541. PubMed
Arterburn D, Livingston E, Olsen M, Smith V, Kavee A, Kahwati L, Henderson W, Maciejewski M. Predictors of initial weight loss after gastric bypass surgery in twelve Veterans Affairs medical centers. Obes Res Clin Pract. 2013 Sep-Oct;7(5):e321-430. doi: 10.1016/j.orcp.2012.02.009. PubMed
Arterburn D, Livingston EH, Schifftner T, Kahwati LC, Henderson WG, Maciejewski ML. Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers. Arch Surg. 2009;144(10):914-20. PubMed
Arterburn D, Maggard MA. Revisiting the 2011 FDA decision on laparoscopic adjustable gastric banding. Obesity (Silver Spring). 2013 Nov;21(11):2204. doi: 10.1002/oby.20476. Epub 2013 Jul 5. PubMed
Arterburn D, McCulloch D. Bariatric Surgery for Type 2 Diabetes: Getting Closer to the Long-term Goal. JAMA. 2016;315(12):1276-7. doi: 10.1001/jama.2016.1884. PubMed
David E. Arterburn, MD, MPHSenior Investigator |
Paula Lozano, MD, MPHSenior Investigator; Director, ACT Center |
Allen Cheadle, PhDSenior Investigator, KPWHRI; Senior Research Associate, CCHE |
Dori E. Rosenberg, PhD, MPHSenior Scientific Investigator |
Gregory E. Simon, MD, MPHSenior Investigator |
Andrea J. Cook, PhDSenior Biostatistics Investigator |
Beverly B. Green, MD, MPHSenior Investigator |
Maricela Cruz, PhDAssistant Biostatistics Investigator |
Mikael Anne Greenwood-Hickman, MPHCollaborative Scientist |
Laurel Hansell, MA, MPHCollaborative Scientist |
Nicole M. Gatto, PhD, MPHPrincipal Collaborative Scientist |